Genscript Biotech Correlations
| GNNSF Stock | USD 1.25 0.01 0.79% |
The current 90-days correlation between Genscript Biotech and Innovent Biologics is -0.11 (i.e., Good diversification). The correlation of Genscript Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Genscript Biotech Correlation With Market
Significant diversification
The correlation between Genscript Biotech and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and DJI in the same portfolio, assuming nothing else is changed.
Genscript |
The ability to find closely correlated positions to Genscript Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genscript Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genscript Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genscript Biotech to buy it.
Moving together with Genscript Pink Sheet
Moving against Genscript Pink Sheet
| 0.7 | SLF | Sun Life Financial | PairCorr |
| 0.46 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.38 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
| 0.31 | SIGL | Signal Advance | PairCorr |
| 0.69 | WMT | Walmart | PairCorr |
| 0.67 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.66 | HD | Home Depot | PairCorr |
| 0.63 | DIS | Walt Disney | PairCorr |
| 0.59 | PYPL | PayPal Holdings Aggressive Push | PairCorr |
| 0.58 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.56 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.42 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.4 | CSCO | Cisco Systems | PairCorr |
| 0.39 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Genscript Pink Sheet performing well and Genscript Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Genscript Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TLPPF | 2.82 | 0.32 | 0.07 | (2.07) | 2.93 | 5.55 | 13.75 | |||
| KROS | 3.55 | (1.02) | 0.00 | (0.24) | 0.00 | 6.18 | 82.94 | |||
| ZNTL | 4.31 | (0.09) | 0.01 | 0.06 | 5.41 | 11.41 | 33.76 | |||
| IVBXF | 1.61 | (0.17) | 0.00 | (0.98) | 0.00 | 4.92 | 24.34 | |||
| CLRPF | 4.29 | (0.72) | 0.00 | 16.57 | 0.00 | 11.14 | 27.06 | |||
| ONTTF | 4.10 | 0.17 | 0.03 | 0.26 | 4.08 | 12.03 | 25.17 | |||
| NUVL | 2.17 | (0.01) | 0.03 | 0.09 | 2.80 | 3.84 | 36.85 | |||
| CRNX | 1.81 | 0.02 | 0.00 | 0.11 | 2.83 | 4.04 | 16.75 | |||
| INBX | 2.16 | (0.11) | 0.00 | (0.01) | 0.00 | 4.92 | 16.07 | |||
| MRUS | 1.95 | (0.30) | 0.00 | (0.15) | 0.00 | 3.33 | 13.01 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Genscript Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Genscript Biotech Corporate Management
| Shiniu Wei | Chief Officer | Profile | |
| Brian Min | CEO Bus | Profile | |
| Zhenyu Liu | Chief Officer | Profile | |
| Weihui Shao | Chief Officer | Profile | |
| Chifa Zhang | Department head - industry synthetic biology product segment | Profile |